Furthermore, a retrospective study found that (33) patients with PCOS and MS typically exhibited lower-quality embryos and an increased concentration of Fetuin-A in the follicular fluid, which negatively impacted embryo and, consequently, live birth rates. The gene discussed is AHSG; the disease is myeloid sarcoma.